Global Blood Therapeutics GBT

$ 68.49 0.0%

Quarterly report 2022-Q2
added 08-08-2022

Global Blood Therapeutics EV/EBITDA Ratio 2011-2024 | GBT

Annual EV/EBITDA Ratio Global Blood Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-6.46	-11.7	-13.4	-12.1	-19.8	-4.94	-2.06	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-2.06	-19.8	-10.1